"Researchers are making progress toward understanding how some cases of glaucoma begin. A new study from the National Eye Institute reveals that myocilin—a protein linked to a significant fraction of glaucoma—is needed to insulate peri"...
Xibrom Patient Information including How Should I Take
In this Article
- What is bromfenac ophthalmic (Xibrom)?
- What are the possible side effects of bromfenac ophthalmic (Xibrom)?
- What is the most important information I should know about bromfenac ophthalmic
- What should I discuss with my healthcare provider before using bromfenac ophthalmic (Xibrom)?
- How should I use bromfenac ophthalmic (Xibrom)?
- What happens if I miss a dose (Xibrom)?
- What happens if I overdose (Xibrom)?
- What should I avoid while using bromfenac ophthalmic (Xibrom)?
- What other drugs will affect bromfenac ophthalmic (Xibrom)?
- Where can I get more information?
What should I discuss with my healthcare provider before using bromfenac ophthalmic (Xibrom)?
You should not use this medication if you are allergic to bromfenac.
To make sure you can safely use bromfenac ophthalmic, tell your doctor if you have any of these other conditions:
- asthma or sulfite allergy;
- rheumatoid arthritis;
- dry eye syndrome;
- an allergy to aspirin or other NSAIDs;
- a bleeding or blood-clotting disorder; or
- more than one eye surgery in a short period of time.
FDA pregnancy category C. It is not known whether bromfenac ophthalmic will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.
It is not known whether bromfenac ophthalmic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I use bromfenac ophthalmic (Xibrom)?
Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Do not use this medication while wearing contact lenses.
The Bromday brand of bromfenac ophthalmic is usually given as 1 drop in each affected eye once daily for 14 days. You will use the first dose 1 day before your surgery.
The Xibrom brand of bromfenac ophthalmic is usually given as 1 drop in each affected eye twice daily for 14 days. You will use the first dose 24 hours after your surgery.
Follow your doctor's dosing instructions very carefully. Do not use this medication for more than the number of days your doctor has recommended. Using a steroid eye drop too long can increase your risk of serious side effects that may damage your vision.
Wash your hands before using eye medication.
To apply the eye drops:
- Tilt your head back slightly and pull down your lower eyelid to create a small pocket. Hold the dropper above the eye with the tip down. Look up and away from the dropper as you squeeze out a drop, then close your eye.
- Use only the number of drops your doctor has prescribed.
- Gently press your finger to the inside corner of the eye (near your nose) for about 1 minute to keep the liquid from draining into your tear duct.
- Wait at least 10 minutes before using any other eye drops that your doctor has prescribed.
Do not allow the tip of the dropper to touch any surface, including your eyes or hands. If the dropper becomes contaminated it could cause an infection in your eye, which can lead to vision loss or serious damage to the eye.
Do not use the eye drops if the liquid has changed colors or has particles in it. Call your doctor for a new prescription.
Store at room temperature away from moisture and heat. Do not freeze. Keep the bottle tightly closed when not in use.
Additional Xibrom Information
- Xibrom Drug Interactions Center: bromfenac opht
- Xibrom Side Effects Center
- Xibrom Overview including Precautions
- Xibrom FDA Approved Prescribing Information including Dosage
Xibrom - User Reviews
Xibrom User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get breaking medical news.